Drug intelligence / Profile preview

NasoClenz

Development stage
Unknown
Lead developer
Silicon Valley Innovations
Modality
Small Molecules
Administration
Topical (intranasal Application)
01

Overview

NasoClenz is an over-the-counter nasal antiseptic cleansing kit consisting of a proprietary cleansing wand and a topical gel whose active ingredient is **benzalkonium chloride 0.13%**. The primary action is to decrease bacteria on the skin of the anterior nasal vestibule, helping to reduce bacteria that can cause skin infections. The gel is specially formulated to be moisturizing, non-alcohol based, and suitable for the sensitive inner nasal lining. The kit is intended to improve nasal hygiene, reduce exposure to airborne pollutants, allergens, and pathogens, and is also marketed for use in people with dry nasal passages (e.g., from CPAP therapy, travel, or allergies). The formulation and product design were developed by Dr. Gail Lebovic in collaboration with med-tech engineers. NasoClenz is made in the USA and complies with FDA requirements[1][2][4][6][7][8][9][10][13][14][15].

Brand names
NasoClenz
Other names
NasoClenz Antiseptic KitNasoClenz Cleansing Kit

Beyond the preview

Go deeper on NasoClenz.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NasoClenz.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call